(19)
(11) EP 3 360 492 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.11.2020 Bulletin 2020/45

(45) Mention of the grant of the patent:
26.08.2020 Bulletin 2020/35

(21) Application number: 18162238.2

(22) Date of filing: 22.01.2013
(51) International Patent Classification (IPC): 
A61B 17/3205(2006.01)
A61B 17/94(2006.01)
A61M 31/00(2006.01)
 A61B 17/42(2006.01)
A61B 1/303(2006.01)
A61B 1/018(2006.01)

(54)

MEDICAL DEVICE AND METHODS

MEDIZINISCHE VORRICHTUNG UND VERFAHREN

DISPOSITIF MÉDICAL ET PROCÉDÉS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 20.01.2012 US 201261589168 P
19.04.2012 US 201261635803 P
13.06.2012 US 201261659312 P

(43) Date of publication of application:
15.08.2018 Bulletin 2018/33

(62) Application number of the earlier application in accordance with Art. 76 EPC:
13738378.2 / 2804550

(73) Proprietor: Minerva Surgical, Inc.
Santa Clara, CA 95054 (US)

(72) Inventors:
  • GERMAIN, Aaron
    Campbell, CA California 95008 (US)
  • TRUCKAI, Csaba
    Saratoga, CA California 95070 (US)

(74) Representative: Pfenning, Meinig & Partner mbB 
Patent- und Rechtsanwälte Joachimsthaler Straße 10-12
10719 Berlin
10719 Berlin (DE)


(56) References cited: : 
WO-A1-2013/044243
US-A1- 2011 224 486
 US-A- 5 749 889
US-A1- 2012 010 464
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).